A method of treating a mammal with an adiponectin mediated disorder comprising administering a therapeutically effective amount of an adiponectin variant with at least a 3-fold increased solubility relative to residues 110-244 of human adiponectin.

 
Web www.patentalert.com

< Jucara and acai fruit-based dietary supplements

< Laser-decomposable resin composition and pattern-forming material using the same

> N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives

> Compositions and methods for treatment of cancer
~ 00620